阿司匹林预防膝关节置换术后下肢深静脉血栓的疗效和安全性(3)
[3]Scott C，Woller MD，Kim C， et al. A Prospective Comparison of Warfarin to Aspirin for Thromboprophylaxis in Total Hip and Total Knee Arthroplasty[J].The Journal of Arthroplasty，2012，27(1)：1-9.
[4]Federico L，Alessandro S， EleonoraTP， et al. A systematic review on the effect of aspirin in the prevention of post-operative arterial thrombosis in patients undergoing total hip and total knee arthroplasty[J].Thrombosis Research，2014，134，(3)，2014：599-603.
[5]Mahmoudi M， Sobieraj DM.The cost-effectiveness of oral direct factor Xa inhibitors compared with low-molecular-weight heparin for the prevention of venous thromboembolism prophylaxis in total hip or knee replacement surgery[J].Pharmacotherapy 2013，33(12)：1333-1339.
[6]McDougall CJ，Gray HS，Simpson PM，et al.Complications related to therapeutic anticoagulation in total hip arthroplasty[J].J Arthroplasty 2013，28(1)：187-186.
[7]Reza M T，Mohammad R，Rasouli，MD，et al. Cost-Effective Prophylaxis Against Venous ThromboembolismAfter Total Joint Arthroplasty： Warfarin Versus Aspirin[J].The Journal of Arthroplasty，2015，30：159-164.
[8]Jacobs JJ.American Academy of Orthopaedic Surgeons clinical practice guideline on： preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty[J].J Bone Joint Surg Am.2012，94(8)：746-753.
[9]柳劍，蒋毅，周乙雄.阿司匹林的历史及其在骨科抗凝治疗中的应用争论[J].中华关节外科杂志(电子版)，2014(8)：253-255.
[10]Lotke PA.The role of aspirin for thromboembolic disease in total joint arthroplasty[J].Am J Knee Surg，1999，12：61-63.
[11]Blom A，Pattison G，whitehouse S，et al.Early death following primary total hip arthroplsaty[J].Acta Orthopaedica，2006，77，3：347-350.
编辑/翟辰万, http://www.100md.com(刘泽朋 荣绍远 李春洪 李建华 李玉军)
[4]Federico L，Alessandro S， EleonoraTP， et al. A systematic review on the effect of aspirin in the prevention of post-operative arterial thrombosis in patients undergoing total hip and total knee arthroplasty[J].Thrombosis Research，2014，134，(3)，2014：599-603.
[5]Mahmoudi M， Sobieraj DM.The cost-effectiveness of oral direct factor Xa inhibitors compared with low-molecular-weight heparin for the prevention of venous thromboembolism prophylaxis in total hip or knee replacement surgery[J].Pharmacotherapy 2013，33(12)：1333-1339.
[6]McDougall CJ，Gray HS，Simpson PM，et al.Complications related to therapeutic anticoagulation in total hip arthroplasty[J].J Arthroplasty 2013，28(1)：187-186.
[7]Reza M T，Mohammad R，Rasouli，MD，et al. Cost-Effective Prophylaxis Against Venous ThromboembolismAfter Total Joint Arthroplasty： Warfarin Versus Aspirin[J].The Journal of Arthroplasty，2015，30：159-164.
[8]Jacobs JJ.American Academy of Orthopaedic Surgeons clinical practice guideline on： preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty[J].J Bone Joint Surg Am.2012，94(8)：746-753.
[9]柳劍，蒋毅，周乙雄.阿司匹林的历史及其在骨科抗凝治疗中的应用争论[J].中华关节外科杂志(电子版)，2014(8)：253-255.
[10]Lotke PA.The role of aspirin for thromboembolic disease in total joint arthroplasty[J].Am J Knee Surg，1999，12：61-63.
[11]Blom A，Pattison G，whitehouse S，et al.Early death following primary total hip arthroplsaty[J].Acta Orthopaedica，2006，77，3：347-350.
编辑/翟辰万, http://www.100md.com(刘泽朋 荣绍远 李春洪 李建华 李玉军)
参见：首页 > 医疗版 > 疾病专题 > 心血管科 > 下肢深静脉血栓